Charcot-Marie-Tooth–Linked Mutant GARS Is Toxic to Peripheral Neurons Independent of Wild-Type GARS Levels

English version České info

Charcot-Marie-Tooth disease type 2D (CMT2D) is a dominantly inherited peripheral neuropathy caused by missense mutations in the glycyl-tRNA synthetase gene (GARS). In addition to GARS, mutations in three other tRNA synthetase genes cause similar neuropathies, although the underlying mechanisms are not fully understood. To address this, we generated transgenic mice that ubiquitously over-express wild-type GARS and crossed them to two dominant mouse models of CMT2D to distinguish loss-of-function and gain-of-function mechanisms. Over-expression of wild-type GARS does not improve the neuropathy phenotype in heterozygous Gars mutant mice, as determined by histological, functional, and behavioral tests. Transgenic GARS is able to rescue a pathological point mutation as a homozygote or in complementation tests with a Gars null allele, demonstrating the functionality of the transgene and revealing a recessive loss-of-function component of the point mutation. Missense mutations as transgene-rescued homozygotes or compound heterozygotes have a more severe neuropathy than heterozygotes, indicating that increased dosage of the disease-causing alleles results in a more severe neurological phenotype, even in the presence of a wild-type transgene. We conclude that, although missense mutations of Gars may cause some loss of function, the dominant neuropathy phenotype observed in mice is caused by a dose-dependent gain of function that is not mitigated by over-expression of functional wild-type protein.

Vyšlo v časopise: Charcot-Marie-Tooth–Linked Mutant GARS Is Toxic to Peripheral Neurons Independent of Wild-Type GARS Levels. PLoS Genet 7(12): e32767. doi:10.1371/journal.pgen.1002399
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002399

Souhrn

Zdroje

1. SkreH 1974 Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clinical Genetics

2. Jani-AcsadiAKrajewskiKShyME 2008 Charcot-Marie-Tooth neuropathies: diagnosis and management. Semin Neurol 28 185 194

3. NicholsonGMyersS 2006 Intermediate forms of Charcot-Marie-Tooth neuropathy: a review. Neuromolecular Med 8 123 130

4. TimmermanVNelisEVan HulWNieuwenhuijsenBWChenKL 1992 The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1 171 175

5. HayasakaKHimoroMSatoWTakadaGUyemuraK 1993 Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 5 31 34

6. BergoffenJSchererSSWangSScottMOBoneLJ 1993 Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262 2039 2042

7. VerhoevenKDe JonghePCoenKVerpoortenNAuer-GrumbachM 2003 Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 72 722 727

8. ZhaoCTakitaJTanakaYSetouMNakagawaT 2001 Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105 587 597

9. ZuchnerSMersiyanovaIVMugliaMBissar-TadmouriNRochelleJ 2004 Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36 449 451

10. BaxterRVBen OthmaneKRochelleJMStajichJEHuletteC 2002 Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 30 21 22

11. CuestaAPedrolaLSevillaTGarcía-PlanellsJChumillasMJ 2002 The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30 22 25

12. EvgrafovOVMersiyanovaIIrobiJVan Den BoschLDierickI 2004 Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 36 602 606

13. JordanovaADe JonghePBoerkoelCFTakashimaHDe VriendtE 2003 Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126 590 597

14. AntonellisAEllsworthRESambuughinNPulsIAbelA 2003 Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 72 1293 1299

15. JordanovaAIrobiJThomasFVan DijckPMeerschaertK 2006 Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38 197 202

16. LatourPThauvin-RobinetCBaudelet-MeryCSoichotPCusinV 2010 A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 86 77 82

17. McLaughlinHMSakaguchiRLiuCIgarashiTPehlivanD 2010 Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet 87 560 566

18. MotleyWWTalbotKFischbeckKH 2010 GARS axonopathy: not every neuron's cup of tRNA. Trends Neurosci 33 59 66

19. AntonellisALee-LinSWasterlainALeoPQuezadoM 2006 Functional Analyses of Glycyl-tRNA Synthetase Mutations Suggest a Key Role for tRNA-Charging Enzymes in Peripheral Axons. J Neurosci 26 10397 10406

20. NangleLZhangWXieWYangXLSchimmelP 2007 Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci USA 104 11239 11244

21. StumMGMcLaughlinHMKleinbrinkELMiersKEAckermanS 2010 An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol Cell Neurosci 46 432 443

22. XieWNangleLAZhangWSchimmelPYangXL 2007 Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase. Proc Natl Acad Sci U S A 104 9976 9981

23. XieWSchimmelPYangXL 2006 Crystallization and preliminary X-ray analysis of a native human tRNA synthetase whose allelic variants are associated with Charcot-Marie-Tooth disease. Acta Crystallogr Sect F Struct Biol Cryst Commun 62 1243 1246

24. CaderMZRenJJamesPABirdLETalbotK 2007 Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy. FEBS Lett 581 2959 2964

25. SeburnKLNangleLCoxGASchimmelPBurgessRW 2006 An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 51 715 726

26. AchilliFBros-FacerVWilliamsHPBanksGTAlqatariM 2009 An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Model Mech 2 359 373

27. NiwaHYamamuraKMiyazakiJ 1991 Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 193 199

28. ChiharaTLuginbuhlDLuoL 2007 Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization. Nat Neurosci 10 828 837

29. StorkebaumELeitao-GoncalvesRGodenschwegeTNangleLMejiaM 2009 Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy. Proc Natl Acad Sci U S A 106 11782 11787

30. GautamMNoakesPGMoscosoLRuppFSchellerRH 1996 Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85 525 535

31. VerhageMMaiaASPlompJJBrussaardABHeeromaJH 2000 Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 287 864 869

32. MisgeldTBurgessRWLewisRMCunninghamJMLichtmanJW 2002 Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. Neuron 36 635 648

33. DawkinsJLHulmeDJBrahmbhattSBAuer-GrumbachMNicholsonGA 2001 Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 27 309 312

34. BejaouiKWuCSchefflerMDHaanGAshbyP 2001 SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 27 261 262

35. PennoAReillyMMHouldenHLauraMRentschK 2010 Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 285 11178 11187

36. EichlerFSHornemannTMcCampbellAKuljisDPennoA 2009 Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1. J Neurosci 29 14646 14651

37. BruijnLIHouseweartMKKatoSAndersonKLAndersonSD 1998 Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 1851 1854

38. DevlinEEDacostaLMohandasNElliottGBodineDM 2010 A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia. Blood 116 2826 2835

39. PottsWTuckerDWoodHMartinC 2000 Chicken beta-globin 5′HS4 insulators function to reduce variability in transgenic founder mice. Biochem Biophys Res Commun 273 1015 1018

40. NagyA 2003 Manipulating the mouse embryo : a laboratory manual Cold Spring Harbor, N.Y. Cold Spring Harbor Laboratory Press viii 764

41. ArroyoEJSirkowskiEEChitaleRSchererSS 2004 Acute demyelination disrupts the molecular organization of peripheral nervous system nodes. J Comp Neurol 479 424 434

42. BeebeKWaasWDruzinaZGuoMSchimmelP 2007 A universal plate format for increased throughput of assays that monitor multiple aminoacyl transfer RNA synthetase activities. Anal Biochem 368 111 121

43. BurgessRWCoxGASeburnKL 2009 Neuromuscular disease models and analysis. Methods Mol Biol 602 347 393